HEXO Corp. (TSX:HEXO), one of the Canadian cannabis stocks, Monday reported the completion of its first harvest at its one million sq. ft. greenhouse expansion, marking an important execution milestone for the Company.

HEXO has become a global cannabis company, operating 1.8 million sq. ft. of facilities in Ontario and Quebec and a foothold in Greece to serve the European markets.

On April 1, U.S. cannabis operator Cresco Labs Inc. (CSE:CL) announced its definitive agreement to acquire all shares of Origin House (CSE:OH) for C$1.1 billion.

As it is considered the largest public company acquisition in the U.S. cannabis sector to date, investors are fired up once again about cannabis in the U.S.

The Canada-listed U.S. cannabis stocks we’ve identified today have produced stellar gains on a year-to-date basis.

*Share prices as at April 1, 2019, data obtained from S&P Capital IQ

It’s been five and a half months since Canada legalized recreational weed and, up until a recent trip to Alberta, I hadn’t been able to buy any in person. As a born and bred Vancouverite who now calls Toronto home, there's something that feels ironic about that.

When the federal government introduced the Cannabis Act in April 2017, it left retail rollouts up to the individual provinces and territories. For the most part, (with the notable exception of Quebec), the provinces have mirrored cannabis sales after their liquor retail models.

The future of the marijuana industry is not set to go up in smoke. The future, in fact, looks to be smoke-free.

At least, that’s the view of Quebec-based licensed producer HEXO, which is focused on keeping cannabis users close and non-cannabis users even closer. “That’s why we are focused on cannabis experience that’s beyond smoking,” confirms Pierre Killeen, strategic business development manager at HEXO Corp.

The hemp/CBD phenomena grows. Investors appear to be catching on. Our universe of publicly traded CBD "pure-plays" suggests the two "best-of-breed."

Canadian marijuana stocks, in general, delivered sizzling performances in the first quarter of this year. Many stocks generated greater returns in the quarter than they did in all of 2018.

Among the biggest players in the cannabis industry, there was one clear winner. Aurora Cannabis(NYSE:ACB) handily outperformed both Canopy Growth (NYSE:CGC) and Tilray (NASDAQ:TLRY). Why did Aurora's gains beat its top rivals? There were three primary reasons.

Cannabis stocks recovered from Tuesday's tumble and took on Wednesday with fervour, with broad gains sweeping across the US and Canada.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, rose 1% to 307.61. The Horizons Marijuana Life Sciences Index ETF was up 1% at C$21.93.

Buds

CROP Infrastructure Corp (CSE:CROP) (OTCMKTS:CRXPF) shares jumped Wednesday after it announced that its tenant brands, Hempire and Evolution, are now available in 40 retail locations.

Shares were up 4.8% at C$0.33 in Toronto and up 4.6% at US$0.25 in New York on Wednesday midday. 

Anyone who knows anything about the cannabis industry knows that Canada has been leading the charge for quite some time now. Well, this is true, it seems as though other areas such as select states in the U.S. and some countries abroad, have been working to see their day in the marijuana limelight as well.

These areas are additionally working on producing more and more cannabis as the demand continues to rise so that they continue to work toward becoming some of the top producers in the world. While growers are the ones that people focus on most, it seems as though there are other companies in the industry that are hiding a large amount of potential as well. All in all, it is important to just keep an eye out and not judge a company by how it looks on the outside.

Namaste Technologies Inc. (“Namaste” or the “Company“) (TSXV:N.V) (M5BQ.F) (NXTTF) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company’s application for, and has granted, a management cease trade order (the “MCTO“). As previously announced on March 18, 2019 , the application for the MCTO was made by the Company due to a delay in the filing of its audited annual financial statements for the fiscal year ended November 30, 2018 , the accompanying management’s discussions and analysis and the related CEO and CFO certifications (collectively, the “Annual Filings“) by the filing deadline of April 1, 2019 .

Cannabis stocks took a tumble on Tuesday, with broad losses sweeping across the US and Canada.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, dropped 1% to 303.21. The Horizons Marijuana Life Sciences Index ETF was also down 0.37% at C$21.63.

Buds

Bucking the downward trend was Empower Clinics Inc (OTCMKTS:EPWCF) (CSE:EPW). The medical cannabis clinic operator revealed Tuesday it has closed more than $2.9 million in debenture and equity financings that will be put toward strategic acquisitions and working capital.